The most common adverse effects found in the clinical trials were nausea, headache, diarrhea, vomiting, and dizziness.<unk>  has also been found to have hematologic (blood) effects, as shown in Phase-I studies in which subjects exposed to doses longer than 6 days showed a possible dose and duration effect on hematologic parameters. Its safety in patients with decreased levels of white blood cells has not been established. Patients on<unk>  are also at low risk of peripheral and optic neuropathy, similar to other members of the oxazolidinone class.
Tedizolid
Telithromycin
Roxithromycin
Azithromycin
Dirithromycin
Rifampicin
Cadazolid
Gemifloxacin